A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China

Objective: This research aims to analyze the application regularity of Chinese patent medicine during the COVID-19 epidemic by collecting the names of the top three Chinese patent medicines used by 24 hospitals in 14 provinces of China in four time periods (January 20–22, February 16–18, March 01–03...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Zhang, Nan, Shi, Nannan, Li, Siyu, Liu, Guoxiu, Han, Yonglong, Liu, Li, Zhang, Xin, Kong, Xiangwen, Zhang, Bihua, Yuan, Wenpeng, Liu, Yi, Deng, Deqiang, Zheng, Minxia, Zhang, Ying, Li, Lihua, Wang, Xiaoping, Wu, Jiankun, Lin, Xiaolan, Nian, Hua, Wu, Xiaohong, Wang, Hua, Liu, Fang, Wang, Hongli, Wang, Hongshun, Liu, Ying, Zeng, Weixin, Yang, Manqin, Wang, Yanping, Zhai, Huaqiang, Wang, Yongyan
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7990099/
https://ncbi.nlm.nih.gov/pubmed/33776751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.574562
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados